Clinical trial
Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia…
NCT00222027 · University Hospital, Toulouse, Other · Completed
Key facts
| NCT number | NCT00222027 |
|---|---|
| Title | Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial |
| Official title | GRAALL 2003 Trial (ALL 15-59 Years). Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial |
| Acronym | GRAALL2003 |
| Lead sponsor | University Hospital, Toulouse, Other |
| Collaborators | Ministry of Health, France |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Procedure |
| Interventions | Collection of treatment-stratefying prognostic factors |
| Enrollment | 300 |
| Start date | Nov 1, 2003 |
| Primary completion | Oct 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 7, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: